Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Some cloud around but not too chilly!
A man has been given a three-year prison sentence, suspended for two years, for sexually abusing a child in Doncaster in the 1960s.
Over £19k has been raised in 24 hours to repair seven vintage rail carriages that were vandalised in Pickering at the weekend.